SBIR-STTR Award

In Vivo Confocal Microscopy Using MRI Guidance
Award last edited on: 4/26/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$99,986
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Yashvinder S Sabharwal

Company Information

Optical Insights LLC

3440 East Britannia Drive
Tucson, AZ 85706
   (520) 514-8800
   info@optical-insights.com
   www.optical-insights.com
Location: Single
Congr. District: 03
County: Pima

Phase I

Contract Number: 1R43GM058936-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$99,986
Optical Insights, LLC proposes to combine confocal microscopy with magnetic resonance imaging (MRI) to produce a versatile and clinically viable catheter-based system for in-vivo histopathologic evaluation of tissue. Microscopic imaging has long been employed to evaluate biopsy tissue samples at the cellular level. In many applications, however, the biopsy process is fraught with problems including improper selection of tissue for removal and damage to the sample during removal. The catheter- based system proposed here would bring the confocal microscope to the patient allowing microscopic evaluation of the cells while inside the body, thus alleviating the problems associated with tissue biopsy. Since this is a high magnification, small field-of-view system, a guidance mechanism is required to properly position the catheter for tissue evaluation. MRI, which is one of the most sensitive and versatile imaging modalities for visualizing both normal anatomy and pathology, represents a low magnification, wide field-of-view imaging system, which could be used for this purpose. The innovative aspects of this proposal deal with the design and fabrication of the catheter components for MRI compatibility and minimal invasion. The successful marriage of these microscopic and macroscopic imaging modalities would represent a significant advance for in-situ diagnosis of pathologic lesions and tumors. PROPOSED COMMERCIAL APPLICATIONS: Considering that hundreds of thousands of biopsies are performed every year, this system would have a significant impact by enhancing diagnostic capabilities, leading to earlier detection of pathology. Novel technologies which demonstrate better performance and minimize patient discomfort will see immediate acceptance, especially if they have applications to cancer. During the Phase I and Phase II efforts, a serious effort will be undertaken to form alliances with endoscopy companies for the subsequent Phase III effort when FDA approval for the device will be sought. A parallel effort will be made with MRI companies, such as General Electric Corp., to incorporate the real-time tracking capabilities into clinical MRI systems.

Thesaurus Terms:
biomedical equipment development, confocal scanning microscopy, endoscopy, magnetic resonance imaging histopathology, time resolved data bioimaging /biomedical imaging

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----